Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00550290 · ClinicalTrials.gov registry record · Phase 4
Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy
A Phase 4 study, sponsored by Aultman Health Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT00550290: Completed Phase 4 study, sponsored by Aultman Health Foundation.
NCT00550290 is a Phase 4 study that has completed, run by Aultman Health Foundation. The registered enrollment target is 18 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00550290, a Phase 4 study, has completed, sponsored by Aultman Health Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
This randomized prospective study will specifically investigate the efficacy of a 24 hour post-operative course of broad-spectrum prophylactic antibiotics - namely Cefazolin - in preventing wound infection and wound breakdown following vulvectomy.
Primary Outcome
Number of participants experiencing wound complications following vulvectomy. The presence of febrile episodes, elevated WBC counts and exam findings will be used to diagnose wound complications.
Interventions
- DRUG Cefazolin PostOperatively
- DRUG Cefazolin Preoperatively
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-04 |
| Phase | Phase 4 |
What the finished NCT00550290 record still lists
NCT00550290 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Cefazolin PostOperatively is the first listed.
NCT00550290 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00550290 about?
NCT00550290 is a clinical study titled "Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy". This randomized prospective study will specifically investigate the efficacy of a 24 hour post-operative course of broad-spectrum prophylactic antibiotics - namely Cefazolin - in preventing wound infection and wound breakdown following vulvectomy.
What is the current status of trial NCT00550290?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2007-10. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00550290?
The interventions under investigation include: Cefazolin PostOperatively (DRUG), Cefazolin Preoperatively (DRUG).
Who is sponsoring clinical trial NCT00550290?
This trial is sponsored by Aultman Health Foundation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00550290's enrollment target sits among peer trials
18 1842nd of 2000 higher than 147 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia